Evidence map›Paper›PMID 42793143›Full record

ArticleBiomolecules2026

Split Intein-Mediated Engineering of Bacteriocins Through Backbone Circularization, Modular Assembly of Chimeras, and Inducible Circularization.

Irene Lafuente, Ester Sevillano, Nuria Peña, Cleopatra Collado, Luis M Cintas, Pablo E Hernández, Estefanía Muñoz-Atienza, Juan Borrero

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Irene LafuenteDepartamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facultad de Veterinaria, Universidad Complutense de Madrid (UCM), Avenida Puerta de Hierro, s/n, 28040 Madrid, Spain.
Ester SevillanoDepartamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facultad de Veterinaria, Universidad Complutense de Madrid (UCM), Avenida Puerta de Hierro, s/n, 28040 Madrid, Spain.
Nuria PeñaDepartamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facultad de Veterinaria, Universidad Complutense de Madrid (UCM), Avenida Puerta de Hierro, s/n, 28040 Madrid, Spain.
Cleopatra ColladoDepartamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facultad de Veterinaria, Universidad Complutense de Madrid (UCM), Avenida Puerta de Hierro, s/n, 28040 Madrid, Spain.
Luis M CintasDepartamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facultad de Veterinaria, Universidad Complutense de Madrid (UCM), Avenida Puerta de Hierro, s/n, 28040 Madrid, Spain.ORCID 0000-0003-4161-0385
Pablo E HernándezDepartamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facultad de Veterinaria, Universidad Complutense de Madrid (UCM), Avenida Puerta de Hierro, s/n, 28040 Madrid, Spain.ORCID 0000-0001-6259-8456
Estefanía Muñoz-AtienzaDepartamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facultad de Veterinaria, Universidad Complutense de Madrid (UCM), Avenida Puerta de Hierro, s/n, 28040 Madrid, Spain.ORCID 0000-0001-6218-1511
Juan BorreroDepartamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facultad de Veterinaria, Universidad Complutense de Madrid (UCM), Avenida Puerta de Hierro, s/n, 28040 Madrid, Spain.ORCID 0000-0002-9203-0551

Funding

Ministerio de Ciencia, Innovación y Universidades CNS2023-144585Ministerio de Ciencia, Innovación y Universidades PID2023-150939OB-I00
6 · The paper itself

Abstract

The increasing prevalence of antimicrobial resistance has renewed interest in bacteriocins and other antimicrobial peptides as promising alternatives to conventional antibiotics. In this context, in vitro cell-free protein synthesis (IV-CFPS) provides a rapid and versatile platform for the production and functional evaluation of bacteriocins, enabling antimicrobial screening without the limitations associated with cellular expression, low production yields, or peptide toxicity. In previous studies, we demonstrated the utility of IV-CFPS for the production and characterization of a broad range of bacteriocins. More recently, integration of IV-CFPS with split intein-mediated ligation (SIML) enabled the production and functional evaluation of circular bacteriocins, thereby expanding the repertoire of bacteriocins accessible to cell-free synthesis and screening. Here, we further expand the capabilities of the IV-CFPS/SIML platform through three complementary bacteriocin engineering strategies. First, SIML was applied to the backbone circularization of naturally linear bacteriocins, demonstrating that SIML-mediated circularization can be extended beyond naturally circular bacteriocins. Second, the platform enabled the modular assembly of chimeric bacteriocins through the ligation of the translocation/receptor-binding (T-R) and cytotoxic (C) domains of either the same or different colicins. Finally, we developed a proof-of-concept inducible protein trans-splicing system in which bacteriocin circularization is triggered by the addition of a complementary split intein component, thereby providing temporal control over peptide activation. These results establish IV-CFPS/SIML as a versatile platform for programmable bacteriocin engineering and substantially expand its applications beyond the production of naturally circular bacteriocins.

Indexed as

BacteriocinsInteinsProtein EngineeringAnti-Bacterial AgentsCell-Free SystemAnti-Bacterial AgentsBacteriocinsantimicrobial peptide engineeringchimeric bacteriocinscircular bacteriocinsin vitro cell-free protein synthesis (IV-CFPS)protein trans-splicingsplit intein-mediated ligation (SIML)

Identifiers

PMID42793143
PMCPMC13604234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.